Le Registre des lobbyistes
| Objets | Détails | Catégories |
|---|---|---|
|
Santé, Sciences et technologies
|
Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.
|
Politique ou Programme
|
|
Affaires autochtones, Santé
|
Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Politique ou Programme
|
|
Développement économique, Emploi et formation, Santé, Industrie, Propriété intellectuelle, Recherche et développement, Sciences et technologies
|
Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
|
Politique ou Programme
|
|
Santé, Industrie, Propriété intellectuelle, Commerce international, Recherche et développement, Sciences et technologies
|
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations
Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.
|
Proposition législative, Projet de loi ou résolution, Règlement
|
|
Affaires autochtones, Santé, Immigration, Industrie, Recherche et développement, Sciences et technologies
|
Policy and Programs
Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.
|
Politique ou Programme
|
Gilead Sciences Canada Inc. is the Canadian affiliate of Gilead Sciences inc. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet need. The company has a focus within the HIV, hepatitis, antiviral agents for pandemic response for COVID-19, inflammatory diseases, oncology and respiratory therapeutic areas.
Paul Petrelli, General Manager
Adresse :
6925 Century Avenue, suite 400
Mississauga, ON L5N 7K2
Canada
Numéro de téléphone :
905-363-8008
Gilead Sciences Canada ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement